Targeting the glutamatergic system to develop novel therapeutics for mood and anxiety disorders

被引:0
|
作者
Saitoh, Akiyoshi [1 ]
Yamada, Mitsuhiko [1 ]
机构
[1] NCNP, NIMH, Dept Neuropsychopharmacol, Kodaira, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
2-S-11-3
引用
收藏
页码:S52 / S52
页数:1
相关论文
共 50 条
  • [1] Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
    Gerard Sanacora
    Carlos A. Zarate
    John H. Krystal
    Husseini K. Manji
    Nature Reviews Drug Discovery, 2008, 7 : 426 - 437
  • [2] Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
    Sanacora, G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 22 - 22
  • [3] Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
    Sanacora, Gerard
    Zarate, Carlos A.
    Krystal, John H.
    Manji, Husseini K.
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (05) : 426 - 437
  • [4] Targeting glutamatergic transmission in the development of novel therapeutics for mood and anxiety disorders
    Sanacora, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S142 - S142
  • [5] Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
    Machado-Vieira, Rodrigo
    Salvadore, Giacomo
    Ibrahim, Lobna A.
    Diaz-Granados, Nancy
    Zarate, Carlos A., Jr.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (14) : 1595 - 1611
  • [6] Targeting synaptic and neural plasticity to develop novel, improved, therapeutics for severe mood disorders
    Manji, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 5 - 5
  • [7] A GLUTAMATERGIC HYPOTHESIS OF MOOD/ANXIETY DISORDERS
    Popoli, M.
    BEHAVIOURAL PHARMACOLOGY, 2011, 22 : E12 - E13
  • [8] Magnetic Resonance Spectroscopy Studies of the Glutamatergic System in Mood Disorders: A Pathway to Diagnosis, Novel Therapeutics, and Personalized Medicine?
    Salvadore, Giacomo
    Zarate, Carlos A., Jr.
    BIOLOGICAL PSYCHIATRY, 2010, 68 (09) : 780 - 782
  • [9] Glutamatergic signaling as a target for the development of novel therapeutics for mood and stress-related disorders
    Paul, I. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S36 - S36
  • [10] The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders
    Machado-Vieira, Rodrigo
    Manji, Husseini K.
    Zarate, Carlos A.
    NEUROSCIENTIST, 2009, 15 (05): : 525 - 539